Critical Diagnostics launches point-of-care cardiac disease test

Critical Diagnostics rolled out its Aspect-LF cardiac disease test for the biomarker ST2, a point-of-care version of the company's lab-based Presage ST2 assay. The test, which Critical aims to make available in Europe and some Asia-Pacific countries later this year, delivers results in about 20 minutes from a single finger prick, assessing a patient's risk of heart failure without sending blood to the lab. The launch makes Aspect-LF the only point-of-care ST2 biomarker test available commercially. Release

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.